Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTiredness is one of the more commonly reported side effects of semaglutide, and it tends to show up earliest in treatment — often in the first few weeks or after a dose increase. It is usually mild and temporary, settling as your body adjusts. That said, fatigue can sometimes signal something that needs attention, so knowing the difference matters. Semaglutide (Wegovy) is a prescription-only medicine; a prescriber assesses whether it is right for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Feeling tired after starting semaglutide is well enough documented that it appears in the Wegovy patient information leaflet. The mechanism is not one neat cause. Semaglutide slows gastric emptying and reduces appetite, which for most people means eating noticeably less. Eat less, and your body's energy supply changes, at least until it adapts. Add to that the fact that the medicine is new to your system, and some degree of fatigue in the first fortnight is a reasonable expectation rather than a warning sign.
Dose increases tend to bring a fresh wave. Each upward step effectively repeats the adjustment period on a slightly larger scale. The pattern of fatigue through the Wegovy dose schedule tends to mirror the GI side-effect curve: most noticeable in the days following a change, then easing. Many people find the tiredness is at its worst the day after the injection and has largely passed by day three or four.
Sleep quality can also shift, particularly if nausea is keeping you from resting well at night. If the tiredness seems tied to disrupted sleep rather than the medicine itself, that is worth noting, and worth raising with your prescriber, because managing nausea well often resolves the sleep issue, and the fatigue with it. You can read more about what tends to drive this kind of tiredness in a broader look at the topic.
It is worth being honest here: if you are eating very little, drinking less fluid than usual, and exercising on top of that, your body is managing a significant change. Fatigue in that context is not purely a medicine effect, it is a signal that your intake needs attention. Protein, in particular, matters. People on semaglutide who are eating substantially less sometimes under-eat protein without realising it, and low protein intake is one of the faster routes to persistent tiredness and muscle loss.
Dehydration compounds this. Nausea can put people off drinking, and if vomiting or diarrhoea is also present, fluid loss accelerates. The full side-effect picture for Wegovy covers the GI effects in more detail, but the short version is: keep fluids up, even when eating feels unappealing.
There is also a subset of people for whom fatigue on a GLP-1 medicine reflects something separate (thyroid function, anaemia, low vitamin D) that simply becomes more noticeable when other things are changing. If you are wondering whether semaglutide can actually cause fatigue or whether something else is at play, that question is worth exploring properly. If tiredness is lasting longer than two to three weeks without any clear dietary explanation, a blood test to rule out an underlying cause is sensible. Your prescriber can advise. More on the physiology behind semaglutide-related tiredness is available if you want the fuller picture.
Most fatigue on semaglutide is self-limiting. Some is not. The following should prompt you to contact a clinician rather than wait it out.
Severe, persistent stomach pain (especially pain that travels to your back, with or without vomiting) needs urgent attention. This can indicate acute pancreatitis, a serious but infrequent complication flagged by the MHRA in a Drug Safety Update for GLP-1 medicines in January 2026. Fatigue alongside this kind of abdominal pain is not a combination to monitor at home.
Fatigue paired with signs of dehydration (dark urine, dizziness on standing, little to no urine output) is another reason to seek same-day medical advice. Kidney function can be affected if severe vomiting or diarrhoea goes uncorrected. Symptoms of a serious allergic reaction (swollen face, throat tightening, difficulty breathing), a rapid or irregular heartbeat, or significant low mood or thoughts of self-harm are all reasons to seek help promptly.
If you are unsure whether what you are feeling is within the expected range, contact your prescriber. At nume, aftercare is available seven days a week, you are not left to work this out on your own. Side effects can also be reported via the MHRA Yellow Card scheme, which helps the regulator track patterns across the UK population and improves safety for everyone on these medicines.
The good news is that for most people fatigue during semaglutide treatment is manageable with fairly straightforward adjustments. Timing your injection at the end of the day so the peak adjustment period happens overnight is one approach worth trying, some people find it meaningfully reduces how tired they feel during waking hours.
Eating protein at every meal, staying hydrated, and not dramatically cutting calories beyond what the reduced appetite naturally brings about all matter here. The NHS guidance on semaglutide on the NHS medicines pages is clear that lifestyle changes work alongside the medicine rather than in competition with it. Light movement, even a short walk, can paradoxically help more than rest alone if the fatigue is mild. For a closer look at how fatigue and semaglutide interact across the course of treatment, including what tends to improve with time and what is worth flagging, there is a dedicated guide available.
If you are finding that tiredness is affecting your daily life weeks into treatment, that is worth discussing at your next clinical review, not because it means treatment is not working, but because there may be a straightforward explanation and a practical fix. Our clinical team reviews every patient before each repeat, not just at the start. That is the point of an ongoing clinical relationship rather than a one-off prescription. If you are exploring whether semaglutide is the right option for your situation, checking your eligibility through a free consultation is the place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.